Nomura Research Institute, Ltd.
NURAF
$36.93
-$1.67-4.34%
OTC PK
| 03/31/2025 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.29B | 1.27B | 1.21B | 1.26B | 1.27B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.29B | 1.27B | 1.21B | 1.26B | 1.27B |
| Cost of Revenue | 832.42M | 818.16M | 772.77M | 811.84M | 822.11M |
| Gross Profit | 457.42M | 451.18M | 434.08M | 444.79M | 451.26M |
| SG&A Expenses | 246.53M | 235.99M | 233.98M | 249.32M | 245.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -629.90K | -5.58M | -8.35M | 4.70M | -11.06M |
| Total Operating Expenses | 1.08B | 1.05B | 998.40M | 1.07B | 1.06B |
| Operating Income | 211.52M | 220.78M | 208.45M | 190.77M | 217.09M |
| Income Before Tax | 213.74M | 224.62M | 205.62M | 188.29M | 215.00M |
| Income Tax Expenses | 68.20M | 65.85M | 62.34M | 62.17M | 55.41M |
| Earnings from Continuing Operations | 145.54M | 158.77M | 143.27M | 126.12M | 159.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.40M | -746.80K | -1.07M | -1.15M | -840.10K |
| Net Income | 144.14M | 158.02M | 142.21M | 124.96M | 158.74M |
| EBIT | 211.52M | 220.78M | 208.45M | 190.77M | 217.09M |
| EBITDA | 292.24M | 302.95M | 287.24M | 272.27M | 300.46M |
| EPS Basic | 0.25 | 0.28 | 0.25 | 0.22 | 0.28 |
| Normalized Basic EPS | 0.23 | 0.24 | -- | 0.20 | 0.23 |
| EPS Diluted | 0.25 | 0.28 | 0.25 | 0.22 | 0.28 |
| Normalized Diluted EPS | 0.23 | 0.24 | -- | 0.20 | 0.23 |
| Average Basic Shares Outstanding | 572.02M | 573.76M | 575.56M | 576.04M | 576.36M |
| Average Diluted Shares Outstanding | 572.02M | 573.76M | 575.70M | 576.25M | 576.63M |
| Dividend Per Share | 0.22 | 0.20 | -- | 0.20 | 0.00 |
| Payout Ratio | -- | -- | -- | 0.01% | 59.48% |